COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Clinical trials for COMMUNITY-ACQUIRED PNEUMONIA (CAP) explained in plain language.
Never miss a new study
Get alerted when new COMMUNITY-ACQUIRED PNEUMONIA (CAP) trials appear
Sign up with your email to follow new studies for COMMUNITY-ACQUIRED PNEUMONIA (CAP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to cut unnecessary antibiotics in kids with pneumonia
Disease control Recruiting nowThis study looks at how to best treat children aged 6 months to 18 years who come to the emergency room with pneumonia but are not sick enough to stay in the hospital. The goal is to see if a new approach can reduce the use of antibiotics that may not be needed, while still helpi…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: NA • Sponsor: Jeffrey Pernica • Aim: Disease control
Last updated May 17, 2026 06:52 UTC
-
Steroid showdown: which drug saves more lives in severe pneumonia?
Disease control Recruiting nowThis study compares two common steroids—hydrocortisone and prednisolone—in adults hospitalized with severe community-acquired pneumonia. The main goal is to see if one reduces deaths within 30 days more than the other. About 1,600 participants will be randomly assigned to receive…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: PHASE4 • Sponsor: Copenhagen Respiratory Research • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Pneumonia patients get heart drug in artery inflammation trial
Disease control Recruiting nowThis study tests if a drug called icosapent ethyl (Vascepa) can reduce inflammation in the arteries of adults hospitalized with community-acquired pneumonia. Inflammation from pneumonia can harm blood vessels, raising heart risks. Over 6 months, 168 participants will take either …
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Could holding off on antibiotics be safer for kids with pneumonia?
Symptom relief Recruiting nowThis study looks at whether a 'watch and wait' strategy (giving antibiotics only if a child doesn't improve after 3 days) works as well as giving antibiotics right away for children with mild pneumonia. About 2,000 children will be randomly assigned to one of the two approaches. …
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
New study aims to slash antibiotic overuse for coughs and colds
Knowledge-focused Recruiting nowThis study tests whether a two-part program can help doctors and pharmacists work together to reduce antibiotic use for respiratory infections like bronchitis, sinusitis, and sore throat. About 4,500 patients will take part. The program includes a tool to show when infections are…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Phase: NA • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC
-
Italian registry launches to track deadly pneumonia in vulnerable patients
Knowledge-focused Recruiting nowThis study aims to better understand pneumonia in adults with weakened immune systems. Researchers will observe about 1,300 hospitalized patients in Italy for one year to learn what causes their infections, how they respond to treatments, and their health outcomes. The goal is to…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Sponsor: Societa Italiana di Pneumologia • Aim: Knowledge-focused
Last updated May 04, 2026 16:22 UTC